Lauxen Jane Sophie, Vondenhoff Sonja, Junho Carolina Victoria Cruz, Martin Philipp, Fleig Susanne, Schütt Katharina, Schulze-Späte Ulrike, Soehnlein Oliver, Prates-Roma Leticia, Döring Yvonne, Baaten Constance C F M J, Noels Heidi
Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany.
Department of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany.
Acta Physiol (Oxf). 2025 Jun;241(6):e70057. doi: 10.1111/apha.70057.
Patients with chronic kidney disease (CKD) are at increased cardiovascular risk. Since neutrophils play a central role in atherosclerosis and cardiovascular disease, this study analyzed neutrophil function in CKD patients.
A systematic review of neutrophil function in CKD patients compared to controls was performed according to PRISMA guidelines by searching PubMed and the Web of Science. A meta-analysis summarized the production of reactive oxygen species (ROS) in CKD patients on dialysis in Forest plots. Influencer outlier analyses evaluated risk of bias.
Overall, 92 studies were included, of which 18 in the meta-analysis. Although study heterogeneity was high, the systematic review identified primarily reduced phagocytosis capacity but increased neutrophil degranulation and basal ROS production in neutrophils from CKD patients on hemodialysis compared to controls. Phagocytosis and basal ROS production were mainly unaltered in non-dialysis dependent CKD patients and CKD patients on peritoneal dialysis. The meta-analysis confirmed increased ROS generation in basal conditions predominantly in CKD patients on hemodialysis (Hedges g = 1.20, 95% CI: [0.32; 2.09]), with an insufficient study number for a clear comparison to CKD patients on peritoneal dialysis. However, upon neutrophil stimulation with sterile inflammatory triggers, ROS production was also increased in neutrophils from patients on peritoneal dialysis (Hedges g = 0.89, 95% CI: [0.34; 1.43]).
Increased degranulation and basal ROS formation were observed in neutrophils of CKD patients on hemodialysis, which could contribute to their increased cardiovascular risk. Future studies should compare neutrophil activity in patients of different CKD stages and comorbidities also in relation to cardiovascular outcomes.
慢性肾脏病(CKD)患者心血管疾病风险增加。由于中性粒细胞在动脉粥样硬化和心血管疾病中起核心作用,本研究分析了CKD患者的中性粒细胞功能。
根据PRISMA指南,通过检索PubMed和科学网,对CKD患者与对照组中性粒细胞功能进行系统评价。一项荟萃分析在森林图中总结了接受透析的CKD患者中活性氧(ROS)的产生情况。影响因素离群值分析评估偏倚风险。
总体纳入92项研究,其中18项纳入荟萃分析。尽管研究异质性较高,但系统评价发现,与对照组相比,接受血液透析的CKD患者中性粒细胞吞噬能力主要降低,但脱颗粒增加且基础ROS产生增加。非透析依赖性CKD患者和接受腹膜透析的CKD患者的吞噬作用和基础ROS产生主要未改变。荟萃分析证实,主要在接受血液透析的CKD患者基础状态下ROS生成增加(Hedges g = 1.20,95%CI:[0.32;2.09]),由于研究数量不足,无法与接受腹膜透析的CKD患者进行明确比较。然而,在用无菌炎症刺激物刺激中性粒细胞后,接受腹膜透析患者的中性粒细胞ROS产生也增加(Hedges g = 0.89,95%CI:[0.34;1.43])。
观察到接受血液透析的CKD患者中性粒细胞脱颗粒增加和基础ROS形成增加,这可能导致其心血管疾病风险增加。未来研究应比较不同CKD阶段和合并症患者的中性粒细胞活性,以及与心血管结局的关系。